UBS Group’s CapForce IBD 50 ETF FFTY Stock Holding History

UBS Group’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-19,800	Closed	-$554K	–	8062
2020 Q1	$554K	Buy	19,800 +200	+1%	+$6.66K	﹤0.01%	3859
2019 Q4	$681K	Buy	+19,600	New	+$663K	﹤0.01%	4561
2018 Q3	–	Sell	-100	Closed	-$4K	–	8063
2018 Q2	$4K	Hold	100	–	–	﹤0.01%	7540
2018 Q1	$3K	Buy	+100	New	+$3.4K	﹤0.01%	7419

Other funds holding FFTY

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

DSCM

Del-Sette Capital Management Schenectady, New York $171M AUM 36.85% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

CFP

Comprehensive Financial Planning East Petersburg, Pennsylvania $188M AUM 48.26% 1-Year Est. Return

UBS Group's FFTY Position: Q2 2026 in Review

UBS Group reduced its CapForce IBD 50 ETF (FFTY) stake by 18% in Q2 2026, selling an estimated $22.4K and leaving 2,645 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #7106.

UBS Group first reported a position in FFTY in Q3 2015 and has held it in 44 quarters since. The position peaked at $22.1M in Q3 2018. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.

UBS Group held 2,645 shares of CapForce IBD 50 ETF worth $115K as of Q2 2026.
UBS Group sold 569 CapForce IBD 50 ETF shares in Q2 2026, an estimated $22.4K.
CapForce IBD 50 ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7106 holding.
UBS Group first reported a position in CapForce IBD 50 ETF in Q3 2015 and has held it in 44 quarters since.
UBS Group's CapForce IBD 50 ETF position peaked at $22.1M in Q3 2018.
33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.